Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

OBJECTIVES: Mortality and worsening of organ function are desirable endpoints for clinical trials in systemic sclerosis (SSc). The aim of this study was to identify factors that allow enrichment of patients with these endpoints, in a population of patients from the European Scleroderma Trials and Re...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Rheum Dis
Autori principali: Becker, Mike, Graf, Nicole, Sauter, Rafael, Allanore, Yannick, Curram, John, Denton, Christopher P, Khanna, Dinesh, Matucci-Cerinic, Marco, de Oliveira Pena, Janethe, Pope, Janet E, Distler, Oliver
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2019
Soggetti:
Systemic Sclerosis
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6788922/
https://ncbi.nlm.nih.gov/pubmed/31227488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2019-215145
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi